ID: ALA5201280

Max Phase: Preclinical

Molecular Formula: C31H48N2O8

Molecular Weight: 576.73

Associated Items:

Representations

Canonical SMILES:  CO[C@@H]1C[C@@]2(CO2)[C@H](O)[C@@H](/C=C/C(C)=C/C[C@@H]2O[C@H](C)[C@H](NC(=O)/C=C\[C@H](C)OC(=O)N3CCCCC3)C[C@@H]2C)O1

Standard InChI:  InChI=1S/C31H48N2O8/c1-20(10-13-26-29(35)31(19-38-31)18-28(37-5)41-26)9-12-25-21(2)17-24(23(4)40-25)32-27(34)14-11-22(3)39-30(36)33-15-7-6-8-16-33/h9-11,13-14,21-26,28-29,35H,6-8,12,15-19H2,1-5H3,(H,32,34)/b13-10+,14-11-,20-9+/t21-,22-,23+,24+,25-,26+,28-,29+,31+/m0/s1

Standard InChI Key:  QVARHCCVCHWNOD-RQFNMGTPSA-N

Associated Targets(Human)

MES-SA/Dx5 643 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

MES-SA 905 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

HEK-293T 167025 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Topical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 576.73Molecular Weight (Monoisotopic): 576.3411AlogP: 3.64#Rotatable Bonds: 9
Polar Surface Area: 119.09Molecular Species: NEUTRALHBA: 8HBD: 2
#RO5 Violations: 1HBA (Lipinski): 10HBD (Lipinski): 2#RO5 Violations (Lipinski): 1
CX Acidic pKa: 12.91CX Basic pKa: CX LogP: 3.25CX LogD: 3.25
Aromatic Rings: 0Heavy Atoms: 41QED Weighted: 0.24Np Likeness Score: 1.99

References

1. Ghosh AK, Mishevich JL, Jurica MS..  (2021)  Spliceostatins and Derivatives: Chemical Syntheses and Biological Properties of Potent Splicing Inhibitors.,  84  (5.0): [PMID:33974423] [10.1021/acs.jnatprod.1c00100]

Source